Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
467.68
-9.60 (-2.01%)
At close: Jul 31, 2025, 4:00 PM
470.25
+2.57 (0.55%)
After-hours: Jul 31, 2025, 7:33 PM EDT
Accolade Stock Forecast
Stock Price Forecast
The 17 analysts that cover Accolade stock have a consensus rating of "Buy" and an average price target of $587.65, which forecasts a 25.65% increase in the stock price over the next year. The lowest target is $470 and the highest is $680.
Price Target: $587.65 (+25.65%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Accolade stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 8 | 8 | 7 | 7 | 5 | 4 |
Buy | 8 | 8 | 8 | 8 | 8 | 9 |
Hold | 4 | 4 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 20 | 19 | 19 | 17 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Maintains $460 → $500 | Hold | Maintains | $460 → $500 | +6.91% | Jul 24, 2025 |
Raymond James | Raymond James | Buy Reiterates $525 → $535 | Buy | Reiterates | $525 → $535 | +14.39% | Jul 24, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $570 → $565 | Buy | Maintains | $570 → $565 | +20.81% | Jul 24, 2025 |
Barclays | Barclays | Hold Maintains $450 → $490 | Hold | Maintains | $450 → $490 | +4.77% | Jul 24, 2025 |
Baird | Baird | Buy Maintains $553 → $567 | Buy | Maintains | $553 → $567 | +21.24% | Jul 24, 2025 |
Financial Forecast
Revenue This Year
44.29B
from 42.88B
Increased by 3.28%
Revenue Next Year
46.42B
from 44.29B
Increased by 4.81%
EPS This Year
22.56
from 16.53
Increased by 36.45%
EPS Next Year
24.91
from 22.56
Increased by 10.45%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 46.3B | 50.0B | 53.6B | ||
Avg | 44.3B | 46.4B | 49.2B | ||
Low | 42.5B | 44.1B | 46.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 7.9% | 12.8% | 15.5% | ||
Avg | 3.3% | 4.8% | 5.9% | ||
Low | -0.9% | -0.4% | 0.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 23.84 | 27.30 | 30.18 | ||
Avg | 22.56 | 24.91 | 27.85 | ||
Low | 21.56 | 22.56 | 25.21 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 44.2% | 21.0% | 21.1% | ||
Avg | 36.5% | 10.5% | 11.8% | ||
Low | 30.4% | 0.0% | 1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.